of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO
Status:
Recruiting
Trial end date:
2023-07-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin
and dapagliflozin as monotherapies and the effect of both of them as a combined therapy in
infertile women with PCOs.